Abbonarsi

Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: Determinants and relationship with patient-reported health status - 10/11/24

Doi : 10.1016/j.ahj.2024.08.017 
Camilla Fuchs Andersen, MD a, b, , Massar Omar, MD, PhD c, d, e, Julie Hempel Larsen, MD c, d, e, Caroline Kistorp, MD, PhD b, f, Christian Tuxen, MD, PhD g, Finn Gustafsson, MD, PhD, DMSc h, Lars Køber, MD, PhD h, Mikael Kjær Poulsen, MD, PhD c, Jan Christian Brønd, PhD i, Jacob Eifer Møller, MD, PhD, DMSc c, d, h, Morten Schou, MD, PhD a, b, Jesper Jensen, MD, PhD a, b
a Department of Cardiology, Herlev-Gentofte Hospital, Herlev, Denmark 
b Faculty of Health and Medical Sciences, Copenhagen University, Copenhagen, Denmark 
c Department of Cardiology, Odense University Hospital, Odense, Denmark 
d Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark 
e Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark 
f Department of Endocrinology, Rigshospitalet, Copenhagen, Denmark 
g Department of Cardiology, Frederiksberg-Bispebjerg Hospital, Copenhagen, Denmark 
h Department of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark 
i Department of Sports Science and Clinical Biomechanics, Center for Research in Childhood Health/Unit for Exercise Epidemiology, University of Southern Denmark, Odense, Denmark 

Reprint requests: Camilla Fuchs Andersen, MD, Department of Cardiology, Herlev-Gentofte Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark.Department of CardiologyHerlev-Gentofte HospitalHerlev Ringvej 75HerlevDK-2730Denmark

ABSTRACT

Background

Accelerometer-measured physical activity is an increasingly used endpoint in heart failure (HF) trials. We investigated the determinants of accelerometer-measured physical activity and the relationship with patient-reported health status.

Methods

Post-hoc analysis of the Empire HF trial, including outpatients with HF with reduced ejection fraction (HFrEF). Physical activity was quantified as average accelerometer counts per minute (CPM) with higher values representing higher activity. We investigated associations between activity level and clinical variables, including age, sex, and body mass index, as well as patient-reported health status assessed by Kansas City Cardiomyopathy Questionnaire (KCCQ).

Results

Complete data were available in 180 (95%) patients (86% male, mean age 65 year). Baseline median physical activity level was 1,318 CPM (Q1-Q3 1,111-1,585). Age and anemia were independently associated with activity level (β-coefficients: −10 CPM per year age increase [95% CI −16 to −5.1], P = .00015, and −126 CPM for anemia [95% CI −9.1 to −244], P = .035). Significant independent associations were observed between activity level and all KCCQ summary scores (β-coefficient point estimates of 3.7, 4.6, and 4.9 CPM, all P < .02). For 12-week changes in KCCQ-summary scores, only the KCCQ-CSS was associated with activity level; mean increase of 17.5 CPM [95% CI 1.5 to 34.0], P = 0.032, per 5-point increase in KCCQ-CSS. Associations were not modified by treatment allocation (interaction P-values > .05).

Conclusions

In patients with HFrEF, older age and anemia were independently associated with lower activity. Moreover, physical activity only weakly increased with better health status, suggesting that changes in physical activity reflect improvements in patients’ health status to a limited degree. This highlights the need to better understand the endpoint with regards to all other health parameters to ease interpretation in future HF trials.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




Image, graphical abstract

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2024  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 278

P. 14-23 - dicembre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • Safety and feasibility of triage and rapid discharge of patients with chest pain from emergency room: A pragmatic, randomized noninferiority control trial of the European Society of Cardiology (ESC) 0 to 1 hour pathway vs conventional 0 to 3 hour accelerated diagnostic protocol
  • Aleem Khand, James Hatherley, Ahmed Dakshi, Guy Miller, Lisa Bailey, Michael Fisher, Christopher Goulden, Zaid Noori, Anju Rawat, Rachel Hornby, Hannah Fearon, Nirmol Meah, Sarah Davies, Katarzyna Sekulska, Awtad Hassan, Angela Lambert, Suzannah Phillips, Ray Raj, Tom Wiles, Paul Collinson
| Articolo seguente Articolo seguente
  • Contributors to high left ventricular ejection fraction in women with ischemia and no obstructive coronary artery disease: Results from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) Study
  • Michael D. Nelson, Joanne M. Gomez-Arnold, Janet Wei, Marie Lauzon, Sauyeh K. Zamani, Jenna Maughan, Okezi Obrutu, Chrisandra Shufelt, Eileen Handberg, Carl Pepine, C. Noel Bairey Merz

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.